23 results
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
7 Mar 24
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
8:32am
: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal … company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
)
ATLANTA, January 2, 2024 -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission … Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
)
ATLANTA, December 12, 2023 -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission … with Nasdaq Listing Rule 5635(c)(4).
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
8 Nov 23
Alimera Appoints Maggie A. Pax to Its Board of Directors
5:18pm
) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health … pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision
8-K
EX-99.1
sj9dhf2y
26 Oct 23
Alimera Sciences Reports Third Quarter 2023 Results
7:39am
8-K
EX-99.1
vpctb8lkwmbpuu1
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
8-K
EX-99.1
rp7p8jupd ko
10 Aug 23
Alimera Sciences Reports Second Quarter 2023 Results
8:44am
424B3
rj4zzv em
12 Jul 23
Prospectus supplement
12:00am
8-K
EX-99.1
k7gf02un99
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-99.1
e2r9zidhb7ln6ur12ybo
15 May 23
Alimera Sciences Reports First Quarter 2023 Results
9:05am
8-K
EX-99.1
yysxw4
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
8-K
EX-99.1
i4tem
8 Dec 22
Alimera Sciences Announces Agreement to Extend Amortization Date and Interest-Only Period on Loan Agreement
4:09pm
8-K
EX-99.1
dlk9mwoal7t4gn
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
1oiqu8l0fc4jywoazh
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
EX-99.1
xbzj3hdse2fi8ygdmmpi
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
EX-99.1
637b7
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am